Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 52 citing articles:

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Prevention and Treatment of Acute Graft-versus-Host Disease in Children, Adolescents, and Young Adults
Erin Gatza, Pavan Reddy, Sung Won Choi
Biology of Blood and Marrow Transplantation (2020) Vol. 26, Iss. 5, pp. e101-e112
Open Access | Times Cited: 44
Predictive risk model of mild cognitive impairment in patients with malignant haematological diseases after haematopoietic stem cell transplantation
Si Chen, Ying Zhang, Yuanyuan Feng, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Open Access
A validated risk stratification that incorporates MAGIC biomarkers predicts long term outcomes in pediatric patients with acute GVHD
Muna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 6, pp. 603.e1-603.e11
Open Access | Times Cited: 3
Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease
Kristin Page, Margie Ream, Hemalatha G. Rangarajan, et al.
Blood Advances (2022) Vol. 6, Iss. 9, pp. 2947-2956
Open Access | Times Cited: 14
Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies
Parinda A. Mehta, Seth J. Rotz, Navneet S. Majhail
Biology of Blood and Marrow Transplantation (2018) Vol. 24, Iss. 12, pp. e11-e19
Open Access | Times Cited: 27
Post‐transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)
Neel S. Bhatt, Ruta Brazauskas, Heather R. Tecca, et al.
Cancer (2018) Vol. 125, Iss. 1, pp. 144-152
Open Access | Times Cited: 24
Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms
Rebecca A. Harrison, Noha Sharafeldin, Jennie L. Rexer, et al.
The Oncologist (2021) Vol. 26, Iss. 11, pp. e2021-e2033
Open Access | Times Cited: 20
The Implementation of Chimeric Antigen Receptor (CAR) T-cell Therapy in Pediatric Patients: Where Did We Come From, Where Are We Now, and Where are We Going?
Tristan Knight E, Olalekan O. Oluwole, Carrie L. Kitko
Clinical Hematology International (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2
A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host Disease
Sheila Lahijani, Maria Rueda-Lara, Natalie S. McAndrew, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 9, pp. S493-S512
Open Access | Times Cited: 2
Palliative care during and following allogeneic hematopoietic stem cell transplantation
Sandra A. Mitchell
Current Opinion in Supportive and Palliative Care (2018) Vol. 12, Iss. 1, pp. 58-64
Open Access | Times Cited: 23
A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors
Lisa M. Wu, Nadia Kuprian, Krista Herbert, et al.
Palliative & Supportive Care (2018) Vol. 17, Iss. 04, pp. 396-402
Open Access | Times Cited: 22
Long‐term Follow‐up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics
Ila M. Saunders, Marisela Tan, Divya Koura, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2020) Vol. 40, Iss. 8, pp. 808-841
Closed Access | Times Cited: 19
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States
Neel S. Bhatt, Ruta Brazauskas, Rachel B. Salit, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 8, pp. 679.e1-679.e8
Open Access | Times Cited: 17
Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy
Debra Lynch Kelly, Karen L. Syrjala, Mallory Taylor, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 9, pp. 747-757
Open Access | Times Cited: 15
Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant
Natalie Wu, Kevin R. Krull, Kara L. Cushing‐Haugen, et al.
Journal of Cancer Survivorship (2021) Vol. 16, Iss. 3, pp. 696-704
Open Access | Times Cited: 13
Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders
A. R. Fraser, Paul Castillo, Erika M. Cascio, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 7
Closed Access | Times Cited: 5
CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice
Rachael C. Adams, Dylan Carter‐Cusack, Genesis T. Llanes, et al.
Blood (2023) Vol. 143, Iss. 10, pp. 912-929
Closed Access | Times Cited: 5
Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation
Flora Hoodin, Leah LaLonde, Josh Errickson, et al.
Biology of Blood and Marrow Transplantation (2018) Vol. 25, Iss. 2, pp. 343-353
Open Access | Times Cited: 13
Computerized programs for cancer survivors with cognitive problems: a systematic review
Yoonjung Kim, Sook Jung Kang
Journal of Cancer Survivorship (2019) Vol. 13, Iss. 6, pp. 911-920
Closed Access | Times Cited: 13
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation
Erik Boberg, Nadir Kadri, Daniel W. Hagey, et al.
Leukemia (2023) Vol. 37, Iss. 4, pp. 888-900
Open Access | Times Cited: 4
Psychological Morbidity and Care
Alice Poloméni, Angela Scherwath
Springer eBooks (2024), pp. 265-271
Closed Access | Times Cited: 1
Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation
Erik Boberg, Nadir Kadri, Jeanette Winterling, et al.
Haematologica (2019) Vol. 105, Iss. 6, pp. e310-e314
Open Access | Times Cited: 11
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?
Osnat Bairey, Liat Shargian, Tali Siegal
Acta Haematologica (2020) Vol. 144, Iss. 4, pp. 389-402
Open Access | Times Cited: 10
Gait Analysis of Patients After Allogeneic Hematopoietic Cell Transplantation Reveals Impairments of Functional Performance
Sarah Kneis, Elisa Straub, Isabelle Daniela Walz, et al.
Integrative Cancer Therapies (2020) Vol. 19
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top